# Lyora Therapeutics, Inc. — Form D

Lyora Therapeutics, Inc. of BELMONT, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-11. The offering totals $2.0M, of which $525K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-03-11
- Form: D
- Accession: 0002058969-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $525K
- Remaining: $1.5M
- Investors: 4
- Date of first sale: 2025-02-25
- Revenue range: Decline to Disclose
- SEC file number: 021-540370

## Issuer

- Name: Lyora Therapeutics, Inc.
- CIK: 0002058969
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 118 GODEN STREET, BELMONT, MA, 02478
- Phone: 2157764288

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Eric Pierce, MD, PhD | Director | Belmont, MA |
| Luc Vandenberghe, PhD | Director | Belmont, MA |
| Luc Vandenberghe, PhD | Executive Officer | Belmont, MA |

## More

- [CIK 2058969 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2058969&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002058969-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.